Invicta Diagnostic logo
Listed

smeNSE SME

Invicta Diagnostic

IPO GMP Today

₹0.00

Last updated: 2 Jan 2026 12:03 am

Invicta Diagnostic IPO Subscription Details
LIVE
Last Updated: 2 Jan 2026 12:03 am
QIB3.51x
NII7.27x
bNII7.76x
sNII6.27x
Total4.34x

Overall Subscription Details: No of Apps.: 1772 | 4.34 times

Open

Dec 1, 2025

Close

Dec 3, 2025

BOA

TBA

Refunds

TBA

Listing

TBA

Invicta Diagnostic Issue Details

Pricing & Lot

Price Band

₹80-85

Face Value

₹10 Per Equity Share

Lot Size

TBA

Managers & Listing

Listing At

NSE SME

Lead Managers

Socradamus Capital Pvt Ltd

Registrar

Bigshare Services Pvt Ltd

Issue Size

33,08,800 shares(aggregating up to ₹28.12 crore)

Invicta Diagnostic IPO Reservation
Invicta Diagnostic IPO offers total 3308800 shares. Out of which 534400 (16.15%) allocated to QIB, 542400 (16.39%) allocated to NII,1267200 (38.3%) allocated to RII, NA (NA%) allocated to employees and 798400 (24.13%) allocated to Anchor investors.
Investor CategoryShares OfferedPercentage
Anchor Investor Shares Offered798400 (24.13%)24.13%
Market Maker Shares Offered166400 (5.03%)5.03%
QIB Shares Offered534400 (16.15%)16.15%
NII (HNI) Shares Offered542400 (16.39%)16.39%
bNII > ₹10L361600 (9.39%)9.39%
sNII < ₹10L180800 (4.85%)4.85%
Individual Shares Offered1267200 (38.3%)38.30%
Total Shares Offered3308800 (100%)100.00%
GMP & Listing Expectation

GMP (per share)

0.00

Est. Listing Price

85.00

Total Listing Gain (per lot)

0.00

Grey Market Premium (GMP) is an unofficial market indicator. It reflects the premium investors are willing to pay over the issue price before listing. This is not a guaranteed return and can change rapidly.

Valuations
EPS (Pre IPO)₹5.86/-
EPS (Post IPO)₹6.50/-
Price to Book Value5.26
Market Cap106.86 Cr.
Invicta Diagnostic IPO – FAQs

The Invicta Diagnostic is a 33,08,800 shares(aggregating up to ₹28.12 crore) initial public offering. Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology... You can learn more about what an IPO is in our beginner-friendly guide.

About Invicta Diagnostic

Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.

Invicta Diagnostic Financials
(₹ in crore)
Company Details
Registrar Contact Details

GainIPO data last updated: 01 Jan 2026, 06:33 PM IST

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.